Synthetic Vaccines against Friend Murine Leukaemia Virus-induced Erythroleukaemia: in vivo and in vitro Studies with Synthetic Oligopeptides and Sequence-specific Antisera
نویسندگان
چکیده
منابع مشابه
In vitro and in vivo effects of Peganum harmala L. seeds extract against influenza A virus
Objective: Influenza A virus infections are still a major health problem and the choices available for the control and treatment of the disease are limited. This research evaluated in vitro and in vivo antiviral effects of Peganum harmala L. seeds (PHS) extract against influenza A virus. Materials and Methods: In this research, in vitro anti-influenza A virus activity of the extract was assesse...
متن کاملthe past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group
چکیده ندارد.
in vitro and in vivo synthetic fungicides control of rigidoporus microporus on para rubber in nigeria
rigidoporus microporus is a major threat to hevea brasiliensis in the rubber growing regions of the world. in vitro synthetic fungicidesensitivity assays of tridemorph, benomyl and bayfidan at seven different concentrations, and in vivo effectiveness of the three fungicides on r. microporus inoculated on rubber seedlings were evaluated. the three chemical fungicides used in this study were effe...
متن کاملRhopalurus junceus scorpion venom induces antitumor effect in vitro and in vivo against a murine mammary adenocarcinoma model
Objective(s): In Cuba the endemic scorpion species Rhopalurus junceus has been used in traditional medicine for cancer treatment and related diseases. However there is no scientific evidence about its therapeutic potential for cancer treatment. The aim of the study was to determine the antitumor effect of scorpion venom against a murine mammary adenocarcinoma F3II. <br...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of General Virology
سال: 1987
ISSN: 0022-1317,1465-2099
DOI: 10.1099/0022-1317-68-2-515